focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,096.00
Bid: 12,088.00
Ask: 12,092.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,090.00
High: 12,118.00
Low: 12,038.00
Prev. Close: 12,110.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 keeps head above water as pound sinks

Fri, 19th Aug 2022 17:07

(Alliance News) - The FTSE 100 managed to outperform European counterparts on Friday due to weakness in the pound as consumer confidence in the UK fell to a record low, while attention turns to next week's Jackson Hole Symposium.

The FTSE 100 index closed up 8.52 points, or 0.1%, at 7,550.37, ending the week 0.7% higher.

The FTSE 250 ended down 248.86 points, or 1.2%, at 19,887.79, shedding 2.2% over the course of the week. The mid-cap index is widely considered a more accurate barometer of the UK's economic health due to its domestic exposure.

The AIM All-Share finished down 4.39 points, or 0.5%, at 920.17, losing 1.4% since the start of the week.

The Cboe UK 100 ended up 0.3% at 753.50, the Cboe UK 250 closed down 1.3% at 17,194.58, and the Cboe Small Companies ended down 0.2% at 14,319.05.

In European equities, the CAC 40 stock index in Paris ended down 0.9%, while the DAX 40 in Frankfurt finished 1.1% lower.

"European equities have been hit hard today, as markets start to show signs of a potential impending bearish reversal coming into play. Fortunately for UK investors, the FTSE 100 has managed to perch itself on an island of green, with a collapse in the pound helping to avoid the seemingly inevitable drop into the surrounding red sea. The resurgence in the dollar seen this week serves to highlight the growing feeling that we are on the cusp of another slump, as investors prepare to head for the exit doors once again," said IG Group's Josh Mahony.

In the FTSE 100, drugmakers AstraZeneca and GSK closed up 2.1% and 1.7% respectively.

"The FTSE 100 is outperforming largely due to the weakness of the pound which is helping the big US dollar earners on the index, as well as a strong showing from the more defensive areas of the index, notably health care and GSK and AstraZeneca," explained CMC Markets analyst Michael Hewson.

In the FTSE 250, easyJet lost 6.3% after the budget airline's Spanish pilots began a new three-day work stoppage calling for the reinstatement of conditions they enjoyed before the pandemic, union officials said.

International Consolidated Airlines Group, which owns the flag carrier airline of Spain Iberia, ended the worst blue-chip performer, down 5.1%. Cabin crew at Iberia Express, the low-cost arm of Spain's Iberia national carrier, are also expected to stage a 10-day strike from August 28 to September 6, the USO union has said.

Elsewhere, Cineworld plunged 58% after the Wall Street Journal reported that the movie theatre operator is preparing to declare bankruptcy, as it struggles to recover from pandemic lows.

According to people familiar with the matter, the London-based cinema chain has engaged with lawyers from Kirkland & Ellis LLP and consultants from AlixPartners to advise Cineworld on its bankruptcy process.

Cineworld is expected to fill a chapter 11 petition in the US, and is also considering filing for an insolvency proceeding in the UK.

On Wednesday, Cineworld warned that lacklustre trading was prompting potential financing decisions that could significantly dilute shareholders.

The dollar was higher across the board. The pound was quoted at USD1.1790 at the London equities close, down sharply from USD1.2000 at the close Thursday.

Sterling was dealt a blow after UK consumer confidence hit a record low amid "acute concerns" in the face of the soaring cost of living and bleak economic prospects.

GfK's long-running Consumer Confidence Index fell three points in August to minus 44, its lowest figure since records began in 1974. All five measures that make up the index fell last month, including confidence in personal finances and the general economy.

Confidence in the general economy looking back over the previous year has decreased for eight months in a row to reach minus 68 - some 26 points lower than last August.

The euro stood at USD1.0035 at the European equities close, down from USD1.0132. Against the yen, the dollar was trading at JPY137.15, up sharply from JPY135.10.

Stocks in New York were firmly lower at the London equities close with the US Federal Reserve set to continue on its aggressive rate hike path at its next meeting in September.

Federal Reserve Bank of St. Louis President James Bullard told the Wall Street Journal on Thursday he is considering support for another 75 basis points rate rise at the Fed's policy meeting next month.

Elsewhere, Minneapolis Fed President Neel Kashkari on Thursday said he was insistent that the Fed needed to do more on inflation urgently, even if it meant tipping the economy to the brink of risking a recession.

Meanwhile, US Federal Reserve Chair Jerome Powell will address the who's who of the central banking world in Jackson Hole, Wyoming, on August 26.

The DJIA was down 0.8%, the S&P 500 index down 1.2% and the Nasdaq Composite down 1.9%.

On Wall Street, General Motors was up 2.5% after the automaker said it would reinstate its investor dividend in September and resume "opportunist" share repurchases. GM had suspended payouts at the onset of the pandemic.

Apple was down 1.5% after the tech giant warned of a flaw that is allowing hackers to seize control of iPhones, iPads and Mac computers, and is urging users to install emergency software updates.

Patches were released Thursday and Wednesday by the tech titan to fix what it described as a vulnerability hackers already knew about and may be taking advantage of. However, Apple did not disclose whether it had information regarding the extent to which the issue has been exploited.

"Apple is aware of a report that this issue may have been actively exploited," the Cupertino, California-based company said.

Brent oil was quoted at USD96.45 a barrel at the London stock market close, firm from USD96.12 at the close Thursday.

Gold stood at USD1,748.05 an ounce at the London equities close, lower against USD1,761.70 late Thursday.

The economic events calendar on Monday has the China PBoC loan prime rate announcement overnight.

The UK corporate calendar on Monday has annual results from eConveyancer comparison platform owner Smoove.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.